Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02543931 · ClinicalTrials.gov registry record · Phase 1
Curcuma Longa L in Rheumatoid Arthritis
A Phase 1 study, sponsored by University of Arizona.
- Terminated
- Registry status
- Phase 1
- Development phase
- 3
- Enrollment target
NCT02543931 is a Phase 1 study that was terminated before completion, run by University of Arizona. The registered enrollment target is 3 participants.
The verdict
NCT02543931, a Phase 1 study, was terminated before completion, sponsored by University of Arizona.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to find out whether turmeric dietary supplements that are available over the counter for general use in the United States are safe and useful when taken specifically for the treatment of rheumatoid arthritis (RA) and how the active principles in turmeric are broken down and metabolized by the body in individuals with RA.
Interventions
- DRUG placebo
- DRUG Meriva
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2015-11 |
| Est. Completion | 2017-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02543931
The ClinicalTrials.gov registry entry for NCT02543931 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT02543931 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02543931 about?
NCT02543931 is a clinical study titled "Curcuma Longa L in Rheumatoid Arthritis". The purpose of this study is to find out whether turmeric dietary supplements that are available over the counter for general use in the United States are safe and useful when taken specifically for the treatment of rheumatoid arthritis (RA) and how the active principles in turmeric are broken down ...
What is the current status of trial NCT02543931?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 3 participants. The study started on 2015-11. Estimated completion is 2017-09.
What interventions are being tested in trial NCT02543931?
The interventions under investigation include: placebo (DRUG), Meriva (DRUG).
Who is sponsoring clinical trial NCT02543931?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.